Cargando…

Enhanced Efficacy of Vaccination With Vaccinia Virus in Old vs. Young Mice

Immunosenescence is believed to be responsible for poor vaccine efficacy in the elderly. To overcome this difficulty, research into vaccination strategies and the mechanisms of immune responses to vaccination is required. By analyzing the innate and adaptive immune responses to vaccination with vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shmeleva, Evgeniya V., Smith, Geoffrey L., Ferguson, Brian J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685358/ https://www.ncbi.nlm.nih.gov/pubmed/31417558 http://dx.doi.org/10.3389/fimmu.2019.01780

Ejemplares similares

Suppression of innate immunity by the vaccinia virus protein N1 promotes skin microbiota expansion and increased immune infiltration following vaccination
por: Shmeleva, Evgeniya V., et al.
Publicado: (2022)

Transcriptional reprogramming of natural killer cells by vaccinia virus shows both distinct and conserved features with mCMV
por: Depierreux, Delphine M., et al.
Publicado: (2023)

Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy
por: Sumner, Rebecca P., et al.
Publicado: (2013)

Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators
por: Sumner, Rebecca P., et al.
Publicado: (2016)

Vaccinia Virus Activation and Antagonism of Cytosolic DNA Sensing
por: El-Jesr, Misbah, et al.
Publicado: (2020)

Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model
por: Julander, Justin G., et al.
Publicado: (2018)

Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate
por: Mei, Shan, et al.
Publicado: (2022)

Virus synthesis and replication: reovirus vs. vaccinia virus.
por: Joklik, W. K.
Publicado: (1980)

Virus-specific and shared gene expression signatures in immune cells after vaccination in response to influenza and vaccinia stimulation
por: Quach, Huy Quang, et al.
Publicado: (2023)

Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence
por: Ember, Stuart W. J., et al.
Publicado: (2012)

Limited Effectiveness of Psoralen- and Ultraviolet-Inactivated Vaccinia Virus on SHIV Infection
por: Glenn, L. Lee
Publicado: (2013)

Enhancement of CD8(+) T-cell memory by removal of a vaccinia virus nuclear factor-κB inhibitor
por: Ren, Hongwei, et al.
Publicado: (2015)

Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir
por: Quenelle, Debra C, et al.
Publicado: (2004)

Enhancing the Immunogenicity of Vaccinia Virus
por: Shchelkunov, Sergei N., et al.
Publicado: (2022)

Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors
por: Wei, Min, et al.
Publicado: (2022)

A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection
por: Kubinski, Mareike, et al.
Publicado: (2023)

Single Immunization of a Vaccine Vectored by a Novel Recombinant Vaccinia Virus Affords Effective Protection Against Respiratory Syncytial Virus Infection in Cotton Rats
por: Russell, Marsha S., et al.
Publicado: (2021)

The Host Restriction Factor Interferon-Inducible Transmembrane Protein 3 Inhibits Vaccinia Virus Infection
por: Li, Chang, et al.
Publicado: (2018)

B Cell-Based Vaccine Transduced With ESAT6-Expressing Vaccinia Virus and Presenting α-Galactosylceramide Is a Novel Vaccine Candidate Against ESAT6-Expressing Mycobacterial Diseases
por: Kwon, Bo-Eun, et al.
Publicado: (2019)

Global trends of Vaccinia oncolytic virus therapy over the past two decades: Bibliometric and visual analysis
por: Bo, Liu, et al.
Publicado: (2023)

Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory
por: Albarnaz, Jonas D., et al.
Publicado: (2018)

Oncolytic Vaccinia Virus in Lung Cancer Vaccines
por: Truong, Cao-Sang, et al.
Publicado: (2022)

Thy1(+) Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes
por: Gillard, Geoffrey O., et al.
Publicado: (2011)

Early Pro-Inflammatory Signal and T-Cell Activation Associate With Vaccine-Induced Anti-Vaccinia Protective Neutralizing Antibodies
por: Hou, Jue, et al.
Publicado: (2021)

Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence
por: Ferguson, Brian J., et al.
Publicado: (2013)

Modulation of Cell Surface Receptor Expression by Modified Vaccinia Virus Ankara in Leukocytes of Healthy and HIV-Infected Individuals
por: Leite Pereira, Adrien, et al.
Publicado: (2020)

Modified vaccinia virus Ankara as a vaccine against feline coronavirus: immunogenicity and efficacy
por: Hebben, Matthias, et al.
Publicado: (2004)

Correction: Thy1(+) Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes
por: Gillard, Geoffrey O., et al.
Publicado: (2011)

Molecular and Cellular Dynamics in the Skin, the Lymph Nodes, and the Blood of the Immune Response to Intradermal Injection of Modified Vaccinia Ankara Vaccine
por: Rosenbaum, Pierre, et al.
Publicado: (2018)

Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice
por: Magnusson, Sofia E., et al.
Publicado: (2018)

Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response
por: Paran, Nir, et al.
Publicado: (2013)

Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice
por: Bohnen, C, et al.
Publicado: (2013)

Efficacy of the modified vaccinia Ankara virus vaccine and the replication-competent vaccine ACAM2000 in monkeypox prevention
por: Kandeel, Mahmoud, et al.
Publicado: (2023)

Efficacy of heat against the vaccinia virus, variola virus and monkeypox virus
por: Kampf, G.
Publicado: (2022)

Vaccinia virus utilizes microtubules for movement to the cell surface
por: Hollinshead, Michael, et al.
Publicado: (2001)

Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant
por: Reeman, Sarah, et al.
Publicado: (2017)

Vaccinia Virus Recombinants: Expression Vectors and Potential Vaccines
por: MACKETT, M.
Publicado: (1994)

Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
por: Ma, Jing, et al.
Publicado: (2021)

Enhanced Immune Responses in Mice Induced by the c-di-GMP Adjuvanted Inactivated Vaccine for Pseudorabies Virus
por: Hou, Liting, et al.
Publicado: (2022)

NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice
por: Khan, Arshad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pecnlp7sojv8pihkmt5p5bobnh